Cutaneous manifestations of hepatitis C in the era of new antiviral agents

doi:10.4254/wjh.v7.i27.2740

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13711)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

940

WORD

370

HTML

7137

Figures (1-1)

404

Tables (1-1)

185

Sum=9036

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

559

Download

1051

Sum=1610

Publishing Process of This Article

Item

Count

Browse

1186

Download

1879

Sum=3065

Nov 28, 2015 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Nov 28, 2015; 7(27): 2740-2748
Published online Nov 28, 2015. doi: 10.4254/wjh.v7.i27.2740

Full Size Figure Download Figure

Figure 1 Cutaneous extra-hepatic manifestations of chronic hepatitis C virus infection. A: Cutaneous Lichen planus with inflammatory hyperpigmentation and cicatricial alopecia; B: Erosive oral lichen planus; C: Porphyria cutanea tarda, with typical involvement of sun-exposed acral skin; D: Chronic pruritus with secondary nodular scratch lesions, or prurigo nodularis.

Citation: Garcovich S, Garcovich M, Capizzi R, Gasbarrini A, Zocco MA. Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World J Hepatol 2015; 7(27): 2740-2748
URL: https://www.wjgnet.com/1948-5182/full/v7/i27/2740.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i27.2740